Abstract PR012: Unveiling the Immunoregulatory Role of Tumoral B7-H3 in Promoting the Immunosuppressive TME of Medulloblastoma
Medulloblastoma (MB), the most common embryonal pediatric brain tumor, with a 30% rate of relapse, and relapsed tumors remain practically incurable. While immune checkpoint inhibition (ICI) stands as an alternative treatment, few trials have actually tested its application in MB. Current FDA-approved immune check...